Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CPG-52364 (Synonyms: CPG52364, CPG 52364)

Catalog No. T71461 Copy Product Info
Purity: 99.99%
🥰Excellent
CPG-52364 is a small molecule compound that interacts between an endosomal TLR and its ligand and is a candidate for the treatment of psoriasis.

CPG-52364

Copy Product Info
🥰Excellent
Catalog No. T71461
Synonyms CPG52364, CPG 52364

CPG-52364 is a small molecule compound that interacts between an endosomal TLR and its ligand and is a candidate for the treatment of psoriasis.

CPG-52364
Cas No. 1093135-60-4
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$163In StockIn Stock
5 mg$396In StockIn Stock
10 mg$575In StockIn Stock
25 mg$886In StockIn Stock
50 mg$1,190In StockIn Stock
100 mg$1,630-In Stock
200 mg$2,190-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.99%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

CPG-52364 AI Summary
CPG-52364 exhibits a range of bioactivities, including NFkB signaling pathway agonism, inhibition of cell proliferation (notably against the TMD8 cell line), cytotoxicity, gametocytocidal effects, and potency in immunotoxin sensitization and mitigation studies. It acts as an antagonist at human TLR9 transfected in HEK293 cells with an IC50 of 4.6 nM. The compound also has significant physicochemical properties with three pKa values: 7.93, 6.78, and 5.6, and shows 55.16% binding to plasma proteins. Moreover, it demonstrates good aqueous solubility at pH 7.4, with a solubility of 120.0 ug/mL..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CPG-52364 is a small molecule compound that interacts between an endosomal TLR and its ligand and is a candidate for the treatment of psoriasis.
SynonymsCPG52364, CPG 52364
Chemical Properties
Molecular Weight492.61
FormulaC27H36N6O3
Cas No.1093135-60-4
SmilesN(CCN1CCOCC1)C=2C3=C(N=C(N2)C4=CC=C(C=C4)N5CCN(C)CC5)C=C(OC)C(OC)=C3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 6.88 mg/mL (13.97 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0300 mL10.1500 mL20.3000 mL101.5002 mL
5 mM0.4060 mL2.0300 mL4.0600 mL20.3000 mL
10 mM0.2030 mL1.0150 mL2.0300 mL10.1500 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CPG-52364 | purchase CPG-52364 | CPG-52364 cost | order CPG-52364 | CPG-52364 chemical structure | CPG-52364 formula | CPG-52364 molecular weight